A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

NCT05603312 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

GENETIC: AAV-GAD Low Dose
GENETIC: AAV-GAD High Dose
PROCEDURE: Sham Surgery

Sponsor

MeiraGTx, LLC